Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-06-23
1994-11-15
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530300, 530324, A61K 3700, A61K 3702, C07K 500, C07K 700
Patent
active
053648420
ABSTRACT:
A method of producing analgesia and enhancing opiate analgesia is disclosed. The method includes administering TVIA (SNX-185) or MVIIA (SNX-111) omega-conopeptide, or derivative thereof which is characterized by its ability to (a) inhibit voltage-gated calcium channels selectively in neuronal tissue, as evidenced by the peptide's ability to inhibit electrically stimulated contraction of the guinea pig ileum, and (b) bind to omega-conopeptide MVIIA binding sites present in neuronal tissue.
REFERENCES:
Carta et al., Chemical Abstracts, vol. 114, No. 19, Abst No.: 178244t.
Antkiewicz-Michaluk et al., Chemical Abstracts, vol. 115, No. 21, Abst. No.: 223387a.
Feldman et al., FEBS Lett., vol. 214, No. 2, pp. 295-300 Apr. 1987.
Olivera et al., Biochemistry, vol. 26, pp. 2086-2090, 1987.
Basilico, L., et al., "Influence of .omega.-conotoxin on morphine analgesia and withdrawal syndrome in rats," European Journal of Pharmacology 218(1):75-81 (1992).
Basilico, L., et al., "Interaction of Opiates with .omega.-Conotoxin in Guinea Pig Ileum in Vitro," Pharmacological Research 21(1);65 (1989).
Benedek, G., and M. Sziksza, "Potentiation of thermoregulatory and analgesic effects of morphine by calcium antagonists," Pharmacological Research Communications 16(10):1009 (1984).
Ben-Sreti, M. M., et al., "Effects of elevated calcium and calcium antagonists on 6,7-benzomorphan-induced analgesia," European Journal of Pharmacology, 90:385-391 (1983).
Contreras, E., et al., "Calcium channel antagonists increase morphine-induced analgesia and antagonize morphine tolerance," European Journal of Pharmacology 148:463-466 (1988).
Del Pozo, E., et al., "Analgesic effects of several calcium channel blockers in mice," European Journal of Pharmacology 137:155-160 (1987).
Hoffmeister, F., and D. Tettenborn, "Calcium agonists and antagonists of the dihydropyridine type: Antinociceptive effects, interference with opiate-.mu.-receptor agonists and neuropharmacological actions in rodents," Psychopharmacology 90:299-307 (1986).
Kavaliers, M., "Stimulatory influences of calcium channel antagonists on stress-induced opioid analgesia and locomotor activity," Brain Research 408:403-407 (1987).
Keith, R. A., et al., "Neomycin and .omega.-conotoxin GVIA interact at a common neuronal site in peripheral tisuses," J. Auton. Pharmac. 10: 139-151 (1990).
Knaus, H-G., et al., "Neurotoxic aminoglycoside antibiotics are potent inhibitors [.sup.125 I]-Omega-Conotoxin GVIA binding to guinea-pig cerebral cortex membranes," Naunyn-Schmiedeberg's Arch Pharmacol 336: 583-586 (1987).
Konno, F., and I. Takayanagi, "Relationship between synaptosomal calcium uptake and antinociceptive action of morphine," Japan J. Pharmacol. 33:619-626 (1983).
Lux, F., et al., "Interaction of Morphine with Intrathecally Administered Calcium and Calcium Antagonists: Evidence for Supraspinal Endogenous Opioid Mediation of Intrathecal Calcium-Induced Antinociception in Mice," J. Pharmacol. Exp. Therapeutics 246:500 (1988).
Mackie, K., and B. Hille, "Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells," Proc. Natl. Acad. Sci. USA 89:3825-3829 (1992).
Ocana, M., and J. M. Baeyens, "Analgesic effects of centrally administered aminoglycoside antibiotics in mice," Neuroscience Letters 126:67-70 (1991).
Prado, W. A., et al., "Antinociception induced by intraperitoneal injection of gentamicin in rats and mice," Pain 41:365-371 (1990).
Wagner, J. A., et al., "Aminoglycoside effects on voltage-sensitive calcium channels and neurotoxicity," New England J. Medicine 317(26): 1669 (1987).
Welch, S. P., and W. L. Dewey, "A Characterization of the Antinociception Produced by Intracerebroventricular Injection of 8-(N,N-Diethylamino)Octyl-3,4,5-Trimethoxybenzoate in Mice," J. Pharmacol. Exp. Therapeutics 239:320 (1986).
Woodward, J. J., et al., "Differential sensitivity of synaptosomal calcium entry and endogenous dopamine release to .omega.-conotoxin," Brain Research 475:141-145 (1988).
Gohil Kishor C.
Justice Alan
Singh Tejinder
Valentino Karen L.
Davenport A. M.
Dehlinger Peter J.
Lee Lester L.
Neurex Corporation
Stratford Carol A.
LandOfFree
Method of producing analgesia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of producing analgesia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of producing analgesia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1097815